Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial
  2. Kasirye, Ronnie; Hume, Heather A; Bloch, Evan M; Lubega, Irene; Kyeyune, Dorothy; Shrestha, Ruchee; Ddungu, Henry; Musana, Hellen Wambongo; Dhabangi, Aggrey; Ouma, Joseph; Eroju, Priscilla; de Lange, Telsa; Tartakovsky, Michael; White, Jodie L; Kakura, Ceasar; Fowler, Mary Glenn; Musoke, Philippa; Nolan, Monica; Grabowski, M Kate; Moulton, Lawrence H; Stramer, Susan L; Whitby,Denise; Zimmerman, Peter A; Wabwire, Deo; Kajja, Isaac; McCullough, Jeffrey; Goodrich, Raymond; Quinn, Thomas C; Cortes, Robert; Ness, Paul M; Tobian, Aaron A R
  3. Trials. 2022, Apr 04; 23(1):
  1. 2.   A Randomized Double-Blinded, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
  2. Carter, Melody C; Maric, Irina; Brittain, Erica H; Bai, Yun; Lumbard,Keith; Bolan, Hyejeong; Cantave, Daly; Scott, Linda M; Metcalfe, Dean D
  3. The Journal of allergy and clinical immunology. 2021, Mar; 147(3): 1004-1010.e2.
  1. 3.   INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study
  2. Beigel, John
  3. The Journal of infectious diseases. 2016, Feb 15; 213(4): 574-8.
  1. 4.   Isolated and Skeptical: Social Engagement and Trust in Information Sources Among Smokers
  2. Rutten, L. J. F.; Blake, K.; Hesse, B. W.; Ackerson, L. K.
  3. Journal of Cancer Education. 2011, Sep; 26(3): 465-473.
  1. 5.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 6.   Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging
  2. Jansen, S. A.
  3. Seminars in Ultrasound Ct and Mri. 2011, Aug; 32(4): 306-318.
  1. 7.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 8.   Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
  2. Boltz, V. F.; Zheng, Y.; Lockman, S.; Hong, F. Y.; Halvas, E. K.; McIntyre, J.; Currier, J. S.; Chibowa, M. C.; Kanyama, C.; Nair, A.; Owino-Ong'or, W.; Hughes, M.; Coffin, J. M.; Mellors, J. W.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, May; 108(22): 9202-9207.
  1. 9.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 10.   Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
  2. McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors, J. W.
  3. Antiviral Therapy. 2011 16(5): 725-732.
  1. 11.   Multiplex cytokine analysis technologies
  2. Lash, G. E.; Pinto, L. A.
  3. Expert Review of Vaccines. 2010, Oct; 9(10): 1231-1237.
  1. 12.   Interferon-alpha Produces Significant Decreases in HIV Load
  2. Tavel, J. A.; Huang, C. Y.; Shen, J.; Metcalf, J. A.; Dewar, R.; Shah, A.; Vasudevachari, M. B.; Follmann, D. A.; Herpin, B.; Davey, R. T.; Polis, M. A.; Kovacs, J.; Masur, H.; Lane, H. C.
  3. Journal of Interferon and Cytokine Research. 2010, Jul; 30(7): 461-464.
  1. 13.   ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION
  2. Beigel, J. H.
  3. Drugs of the Future. 2010, May; 35(5): 385-392.
  1. 14.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 15.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 16.   Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy
  2. Su, D. M.; Zhang, Q. Y.; Wang, X. X.; He, P.; Zhu, Y.; Zhao, J. X.; Rennert, O. M.; Su, Y. A.
  3. Molecular Cancer Therapeutics. 2009 8(5): 1292-1304.
  1. 17.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 18.   CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
  2. Read, S. W.; Lempicki, R. A.; Di Mascio, M.; Srinivasula, S.; Burke, R.; Sachau, W.; Bosche, M.; Adelsberger, J. W.; Sereti, I.; Davey, R. T.; Tavel, J. A.; Huang, C. Y.; Issaq, H. J.; Fox, S. D.; Lane, H. C.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(6): 843-850.
  1. 19.   Effect of Adding a Virtual Community (Bulletin Board) to Smokefree.gov: Randomized Controlled Trial
  2. Stoddard, J. L.; Augustson, E. M.; Moser, R. P.
  3. Journal of Medical Internet Research. 2008 10(5): e53.
  1. 20.   O-2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies
  2. Velazquez, C. A.; Rao, P. N. P.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Bioorganic & Medicinal Chemistry. 2007, Jul; 15(14): 4767-4774.
  1. 21.   Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts
  2. Papadopoulou, M. V.; Bloomer, W. D.; Taylor, A. P.; Hernandez, M.; Blumenthal, R. D.; Hollingshead, M. G.
  3. Radiation Research. 2007, Jul; 168(1): 65-71.
  1. 22.   Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
  2. Penzak, S. R.; Kabuye, G.; Mugyenyi, P.; Mbamanya, F.; Natarajan, V.; Alfaro, R. M.; Kityo, C.; Formentini, E.; Masur, H.
  3. HIV Medicine. 2007, Mar; 8(2): 86-91.
  1. 23.   Interferon: Cellular executioner or white knight?
  2. Maher, S. G.; Romero-Weaver, A. L.; Scarzello, A. J.; Gamero, A. M.
  3. Current Medicinal Chemistry. 2007 14(12): 1279-1289.
  1. 24.   Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors
  2. Yazawa, H.; Murakami, T.; Li, H. M.; Back, T.; Kurosaka, K.; Suzuki, Y.; Shorts, L.; Akiyama, Y.; Maruyama, K.; Parsoneault, E.; Wiltrout, R. H.; Watanabe, M.
  3. Cancer Gene Therapy. 2006, Nov; 13(11): 993-1001.
  1. 25.   Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy
  2. Read, S. W.; Higgins, J.; Metcalf, J. A.; Stevens, R. A.; Rupert, A.; Nason, M. C.; Lane, H. C.; Sereti, I.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Aug; 42(5): 537-544.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel